NEW class of pain relievers

There's a lot of interest in a NEW class of pain relievers...COX-2 specific inhibitors.

Searle's Celebra (celecoxib) will be first...Merck's Vioxx isclose behind...others will follow.

These will be BIG. Drug companies are touting them asimproved NSAIDs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote